These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
345 related articles for article (PubMed ID: 32038614)
1. Inhibition of Transglutaminase 2 as a Potential Host-Directed Therapy Against Palucci I; Maulucci G; De Maio F; Sali M; Romagnoli A; Petrone L; Fimia GM; Sanguinetti M; Goletti D; De Spirito M; Piacentini M; Delogu G Front Immunol; 2019; 10():3042. PubMed ID: 32038614 [TBL] [Abstract][Full Text] [Related]
2. Cysteamine/Cystamine Exert Anti- Palucci I; Salustri A; De Maio F; Pereyra Boza MDC; Paglione F; Sali M; Occhigrossi L; D'Eletto M; Rossin F; Goletti D; Sanguinetti M; Piacentini M; Delogu G Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674717 [TBL] [Abstract][Full Text] [Related]
3. Transglutaminase type 2 plays a key role in the pathogenesis of Mycobacterium tuberculosis infection. Palucci I; Matic I; Falasca L; Minerva M; Maulucci G; De Spirito M; Petruccioli E; Goletti D; Rossin F; Piacentini M; Delogu G J Intern Med; 2018 Mar; 283(3):303-313. PubMed ID: 29205566 [TBL] [Abstract][Full Text] [Related]
4. The Activities and Secretion of Cytokines Caused by Delamanid on Macrophages Infected by Multidrug-Resistant Lyu XL; Lin TT; Gao JT; Jia HY; Zhu CZ; Li ZH; Dong J; Sun Q; Shu W; Pan LP; Zhang ZD; Li Q Front Immunol; 2021; 12():796677. PubMed ID: 35003120 [TBL] [Abstract][Full Text] [Related]
5. Pasakbumin A controls the growth of Mycobacterium tuberculosis by enhancing the autophagy and production of antibacterial mediators in mouse macrophages. Lee HJ; Ko HJ; Kim SH; Jung YJ PLoS One; 2019; 14(3):e0199799. PubMed ID: 30865638 [TBL] [Abstract][Full Text] [Related]
6. Bazedoxifene Suppresses Intracellular Mycobacterium tuberculosis Growth by Enhancing Autophagy. Ouyang Q; Zhang K; Lin D; Feng CG; Cai Y; Chen X mSphere; 2020 Apr; 5(2):. PubMed ID: 32269154 [TBL] [Abstract][Full Text] [Related]
7. MIR144* inhibits antimicrobial responses against Mycobacterium tuberculosis in human monocytes and macrophages by targeting the autophagy protein DRAM2. Kim JK; Lee HM; Park KS; Shin DM; Kim TS; Kim YS; Suh HW; Kim SY; Kim IS; Kim JM; Son JW; Sohn KM; Jung SS; Chung C; Han SB; Yang CS; Jo EK Autophagy; 2017 Feb; 13(2):423-441. PubMed ID: 27764573 [TBL] [Abstract][Full Text] [Related]
8. Adjunctive Host-Directed Therapy With Statins Improves Tuberculosis-Related Outcomes in Mice. Dutta NK; Bruiners N; Zimmerman MD; Tan S; Dartois V; Gennaro ML; Karakousis PC J Infect Dis; 2020 Mar; 221(7):1079-1087. PubMed ID: 31605489 [TBL] [Abstract][Full Text] [Related]
9. New tricks for old dogs: countering antibiotic resistance in tuberculosis with host-directed therapeutics. Hawn TR; Shah JA; Kalman D Immunol Rev; 2015 Mar; 264(1):344-62. PubMed ID: 25703571 [TBL] [Abstract][Full Text] [Related]
10. Host-directed therapy targeting the Mycobacterium tuberculosis granuloma: a review. Kiran D; Podell BK; Chambers M; Basaraba RJ Semin Immunopathol; 2016 Mar; 38(2):167-83. PubMed ID: 26510950 [TBL] [Abstract][Full Text] [Related]
11. Cystamine and cysteamine as inhibitors of transglutaminase activity Jeitner TM; Pinto JT; Cooper AJL Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30054429 [TBL] [Abstract][Full Text] [Related]
12. Host Directed Therapies for Tuberculosis: Futures Strategies for an Ancient Disease. Palucci I; Delogu G Chemotherapy; 2018; 63(3):172-180. PubMed ID: 30032143 [TBL] [Abstract][Full Text] [Related]
13. Cystamine and Disulfiram Inhibit Human Transglutaminase 2 via an Oxidative Mechanism. Palanski BA; Khosla C Biochemistry; 2018 Jun; 57(24):3359-3363. PubMed ID: 29570977 [TBL] [Abstract][Full Text] [Related]
16. Repurposing Tamoxifen as Potential Host-Directed Therapeutic for Tuberculosis. Boland R; Heemskerk MT; Forn-Cuní G; Korbee CJ; Walburg KV; Esselink JJ; Carvalho Dos Santos C; de Waal AM; van der Hoeven DCM; van der Sar E; de Ries AS; Xie J; Spaink HP; van der Vaart M; Haks MC; Meijer AH; Ottenhoff THM mBio; 2023 Feb; 14(1):e0302422. PubMed ID: 36475748 [TBL] [Abstract][Full Text] [Related]
17. The Effect of Tuberculosis Antimicrobials on the Immunometabolic Profiles of Primary Human Macrophages Stimulated with Cahill C; Cox DJ; O'Connell F; Basdeo SA; Gogan KM; Ó'Maoldomhnaigh C; O'Sullivan J; Keane J; Phelan JJ Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830070 [TBL] [Abstract][Full Text] [Related]
18. Host-directed therapy with amiodarone in preclinical models restricts mycobacterial infection and enhances autophagy. Kilinç G; Boland R; Heemskerk MT; Spaink HP; Haks MC; van der Vaart M; Ottenhoff THM; Meijer AH; Saris A Microbiol Spectr; 2024 Aug; 12(8):e0016724. PubMed ID: 38916320 [TBL] [Abstract][Full Text] [Related]
19. Macrophage targeted graphene oxide nanosystem synergize antibiotic killing and host immune defense for Tuberculosis Therapy. Pi J; Chen D; Wang J; Yang E; Yang J; Liu Y; Yu J; Xia J; Huang X; Chen L; Ruan Y; Xu JF; Yang F; Shen L Pharmacol Res; 2024 Oct; 208():107379. PubMed ID: 39218421 [TBL] [Abstract][Full Text] [Related]
20. Marine-Fungi-Derived Gliotoxin Promotes Autophagy to Suppress Fu J; Luo X; Lin M; Xiao Z; Huang L; Wang J; Zhu Y; Liu Y; Tao H Mar Drugs; 2023 Nov; 21(12):. PubMed ID: 38132937 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]